GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » K Pharma Inc (TSE:4896) » Definitions » Other Gross PPE

K Pharma (TSE:4896) Other Gross PPE : 円0 Mil (As of Jun. 2024)


View and export this data going back to 2023. Start your Free Trial

What is K Pharma Other Gross PPE?

K Pharma's Other Gross PPE for the quarter that ended in Jun. 2024 was 円0 Mil.

K Pharma Other Gross PPE Historical Data

The historical data trend for K Pharma's Other Gross PPE can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

K Pharma Other Gross PPE Chart

K Pharma Annual Data
Trend Dec21 Dec22 Dec23
Other Gross PPE
- - -

K Pharma Quarterly Data
Dec21 Dec22 Jun23 Sep23 Dec23 Mar24 Jun24
Other Gross PPE Get a 7-Day Free Trial - - - - -

K Pharma Other Gross PPE Calculation

GuruFocus lists Land And Improvements, Buildings And Improvements, Machinery, Furniture, Equipment, Construction In Progress and Other Gross PPE under the "Gross Property, Plant and Equipment" section.

K Pharma Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » K Pharma Inc (TSE:4896) » Definitions » Other Gross PPE
Comparable Companies
TSE:7776 TSE:4888 TSE:4594 TSE:4598 TSE:4588 TSE:4891 TSE:2370 TSE:3750 TSE:4583 TSE:4564 OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
N/A
Address
7-7-7 Roppongi, Minato-ku, Tokyo, JPN, 106-0032
Website
https://en.kpharma.co.jp
K Pharma Inc is a company involved in Research, development, manufacturing, sales and marketing of pharmaceutical products and regenerative medicine products. It is involved in studying of iPs cells in regnerative medecine to treat neurological conditions such as cerebral infarction and SCI.

K Pharma Headlines

No Headlines